image357
image358
image359
image360
image361
image362

The Disorder

Epilepsy is a chronic, neurological disorder, which has been around for 3000 years, and causes unprovoked, recurrent seizures with impacts ranging from social stigma, isolation, injury, and sudden death.

The Numbers

image363

70 Million

3.4 Million

3.4 Million

People with Epilepsy Worldwide

image364

3.4 Million

3.4 Million

3.4 Million

People with Epilepsy in the USA

image365

150,000

3.4 Million

150,000

New Cases Annually in the USA

The PROBLEM

image366

"Endless" Titration Loop

Physicians rely on self reported seizure data to manage their patient's epilepsy - particularly in determining the right medication and the right dose.  However, studies have shown that this data  is up to 50% in accurate.  

image367

Increased Costs while outcomes stagnant

A recent study showed that in the USA, direct costs related to Epilepsy have almost doubled in the last decade to $28B per year, while outcomes have not improved in almost three decades.

THe solution

Using passive oculometric data from consumer grade eye-tracking systems, our software algorithms has the potential to reliably detect seizures and other neurological 'vital signs'.  By employing machine learning capabilities, we expect our software to be able to predict when a seizure will occur.   

The Potential Benefits

image368

Improving Outcomes

Improving Quality of Life

Improving Quality of Life

By helping physicians get the data they need to make timely medical decisions. 

image369

Improving Quality of Life

Improving Quality of Life

Improving Quality of Life

Getting patients on path to seizure freedom quicker and reducing the burden of tracking seizures.

image370

Reducing Costs

Improving Quality of Life

Reducing Costs

Helping providers and patients reduce the number of costly visits to the hospital.

The Evidence

image371

Preliminary

We recently completed a 30 patient proof-of-concept study which resulted in robust seizure detection of the subtlest seizure type, absence seizures.

Upcoming

We are currently preparing for a more in depth clinical study involving several clinical collaborators.

Our Team

image372

Rachel Kuperman, MD, Founder & CEO

Rachel Kuperman, MD, Founder & CEO

Rachel Kuperman, MD, Founder & CEO

Neurologist with dual certification in epilepsy and neurology with over 10 years’ experience directing the clinical epilepsy and research programs at UCSF Benioff Children’s Hospital, Oakland

image373

Jit Sarkar, Co-Founder and CTO

Rachel Kuperman, MD, Founder & CEO

Rachel Kuperman, MD, Founder & CEO

Leads the algorithm development for Eysz solution. He completed his undergraduate degree in computer science and has deep experience applying machine learning methods. His PhD from UCSD focused on extracting signals from a complex medium.

image374

Parth Amin, Co-Founder and Chief Commercial Officer

Parth Amin, Co-Founder and Chief Commercial Officer

Parth Amin, Co-Founder and Chief Commercial Officer

Experienced clinical device development and go-to-market strategist with 15+ years of global medical device and partnership experience. Currently develops and manages our partner ecosystem. 

image375

Nicolle Napier - Ionascu Chief Neuropsychologist

Parth Amin, Co-Founder and Chief Commercial Officer

Parth Amin, Co-Founder and Chief Commercial Officer

Leads the Eysz cognitive research team. Practicing neuropsychology for over 12 years primarily in the Bay Area. She is also the head Neuropsychologist in the Epilepsy department at UCSF Benioff Children’s Hospital Oakland

Our Advisors

image376

Robert Fisher, MD Scientific Advisor

Robert Fisher, MD Scientific Advisor

Robert Fisher, MD Scientific Advisor

Dr. Fisher is Maslah Saul MD Professor and Director of the Stanford Epilepsy Center.   He had research awards from the Klingenstein Foundation, EF, CURE and  NIH. He published 160 peer-reviewed articles and 4 books. He was named  1996-2016 in Best Doctors in America.  He received the Ambassador Award  from the International League Against Epilepsy, the 2005 AES Service  Award and the 2006 Annual Clinical Research Award. 

image377

Hal Blumenfeld, MD Scientific Advisor

Robert Fisher, MD Scientific Advisor

Robert Fisher, MD Scientific Advisor

Dr. Blumenfeld's clinical and research work focuses on epilepsy,  cognition and brain imaging. He directs Yale's Clinical Neuroscience  Imaging Center (CNIC), a new multi-disciplinary core facility for  innovative study and treatment of brain disorders. Teaching activities  include a textbook titled Neuroanatomy Through Clinical Cases, Sinauer  Assoc., Publ. 2002, 2010. 

image378

Peter Milford, PhD Technical Advisor

Peter Milford, PhD Technical Advisor

Peter Milford, PhD Technical Advisor

Dr. Milford has over 15 years experience in developing high technology instrumentation. He was CTO of Eyefluence, which was developing the next generation eye-tracking wearable technology,  up until October 2016, when purchased by Google. He  continued to develop eye interaction and eye tracking for augmented reality (AR) and virtual reality (VR) headsets.  He now serves as the President of Parallel Rules consulting firm.  

image379

Steve Duddy Business Advisor

Peter Milford, PhD Technical Advisor

Peter Milford, PhD Technical Advisor

Steve brings 30+ years of leadership and strategy experience in the Medical Device industry.  He has held a variety of leadership roles in various cross functional areas.  Most recently, he is serving as the President and Chairman of Nuvolase Inc., which has developed the gold standard for Onychomycosis.  Under his leadership, the company has grown in revenues, remained debt-free, and has expanded into new markets. 

Board of Directors

image380

Randy Berholtz JD, MBA

Randy leverages his corporate experience, where he has held roles as a corporate and business development executive and as general counsel, to help nurture over 25 startups in healthcare from funding, to serving as a board of director to corporate and business development and strategic initiatives.  He currently services as a Partner for Ventac Partners and a Senior Advisor for Mesa Partners.  He is also a parent of a child with epilepsy.

Drop us a line with any questions, comments, or inquiries you may have or if you want to simply stay in touch.